Kiveroxa 20 (Rivaroxaban (20mg))

Kiveroxa-20 contains Rivaroxaban (20 mg) an oral anticoagulant designed to prevent and treat blood clots in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). By selectively inhibiting Factor Xa Kiveroxa-20 effectively lowers the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. This convenient once-daily dosing option makes it ideal for individuals seeking reliable anticoagulation therapy.